Fluidigm Announces Agenda for 9th Annual Mass Cytometry Summit
Virtual Event Showcases CyTOF Technology and Its Use in High-Parameter Suspension Mass Cytometry and Imaging Mass CytometryLeading Academic and Pharma […]
Equillium Announces Successful Completion of FDA Pre-IND Meeting Enabling Advancement of Itolizumab into a Potential Registration Study as a Treatment for Hospitalized COVID-19 Patients
Equillium anticipates filing a U.S. IND for Itolizumab for COVID-19 and initiating a global Phase 3 clinical study in Q4 […]
VBL Therapeutics to Provide an Update on the OVAL Study Today at the H. C. Wainwright 22nd Annual Global Investment Conference
TEL AVIV, Israel, Sept. 15, 2020 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT) will present today a corporate overview, including […]
Genetic Technologies Provides Update on COVID-19 Disease Severity Test Development
MELBOURNE, Australia, Sept. 15, 2020 (GLOBE NEWSWIRE) — Molecular diagnostics company Genetic Technologies Limited (ASX: GTG, NASDAQ:GENE) (“Genetic Technologies” or […]
EDAP Hosting Key Opinion Leader Call on Focal One® and ExactVu™
Call to be Held Tuesday, September 22nd @ 8am Eastern TimeLYON, France, September 15, 2020 — EDAP TMS SA (Nasdaq: […]
UNITY Biotechnology Announces Actions to Focus on Senolytic Programs in Ophthalmology and Neurology
– Corporate restructuring to extend cash runway through mid-2022 and key milestones –– UBX1325 to enter clinical development in patients […]
Lightbridge CEO to Discuss Innovative Nuclear Technology on Atlantic Council’s EnergySource Innovation Stream
‘EnergySource Innovation Stream with Lightbridge’ Scheduled for Streaming on September 17 at 8:30 a.m. (Eastern Time)RESTON, Va., Sept. 15, 2020 […]
Momenta Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Proposed Sale to Johnson & Johnson
CAMBRIDGE, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA, “Momenta” or the “Company”), a biotechnology company focused […]
AzurRx BioPharma Announces Two Abstracts Accepted for Presentation at the 2020 North American Cystic Fibrosis Virtual Conference
Abstracts to Focus on:Results from Phase 2, Open-Label, Multicenter, 2×2 Cross-Over Trial to Assess Safety and Efficacy of MS1819 in […]
Gritstone Oncology Announces Updated Presentation Time at Cantor Virtual Global Healthcare Conference
EMERYVILLE, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) — Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next […]
